The weather is turning and the maples on my street are turning brilliant colors. (Arboretum #68) #generativeart.
30 Oct 2023, 12:12
GM! The weather is turning and the maples on my street are turning brilliant colors! (Arboretum #68) #generativeart
Same news in other sources
3
30 Oct 2023, 12:40
Triall Insights š
According to the IQVIA Institute, the past 5 years has seen a significant number of first-in-class medicines.
In 2022, 62% of launches included first-in-class therapies (spread across nearly all major therapeutic areas), reflecting the increasing availability of novel science for patients.
Source: iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2023
š£ļø Help us spread the news:
#blockchainforhealth #TRL
Triall Insights. According to the IQVIA Institute, the past 5 years has seen a significant number of first-in-class medicines.
Triall Insights š
According to the IQVIA Institute, the past 5 years has seen a significant number of first-in-class medicines.
In 2022, 62% of launches included first-in-class therapies (spread across nearly all major therapeutic areas), reflecting the increasing availability of novel science for patients.
Source: iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2023
š£ļø Help us spread the news:
https://x.com/triallofficial/status/1718970891608973399?s=20
#blockchainforhealth #TRL
30 Oct 2023, 12:40
Triall Insights š
According to the IQVIA Institute, the past 5 years has seen a significant number of first-in-class medicines.
In 2022, 62% of launches included first-in-class therapies (spread across nearly all major therapeutic areas), reflecting the increasing availability of novel science for patients.
Source: iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2023
š£ļø Help us spread the news:
#blockchainforhealth #TRL
Triall Insights. According to the IQVIA Institute, the past 5 years has seen a significant number of first-in-class medicines.
Triall Insights š
According to the IQVIA Institute, the past 5 years has seen a significant number of first-in-class medicines.
In 2022, 62% of launches included first-in-class therapies (spread across nearly all major therapeutic areas), reflecting the increasing availability of novel science for patients.
Source: iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2023
š£ļø Help us spread the news:
https://x.com/triallofficial/status/1718970891608973399?s=20
#blockchainforhealth #TRL
30 Oct 2023, 12:26
āØ October Ecosystem Update āØ
The October Ecosystem Update is here!
Check out all the new integrations, events & updates from the month of October at Interlay
October Ecosystem Update. The October Ecosystem Update is here.
āØ October Ecosystem Update āØ
The October Ecosystem Update is here!
Check out all the new integrations, events & updates from the month of October at Interlay
https://medium.com/interlay/october-ecosystem-update-76ce7d0dcf5b